Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib with Chemoradiation in Newly Diagnosed Glioblastoma
NCT01062425Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2010
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in glioblastoma (GBM), sponsored by National Cancer Institute. Started Feb 2010; status: completed.
02
Drugs
cediranib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01062425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01062425.